Directors & Officers
| Name | Title | Year Born |
|---|---|---|
| Ms. Karina M. Fedasz | Interim Chief Financial Officer | 1973 |
| Mr. David Allan White C.A., C.P.A., ICD.D | Chief Executive Officer | 1953 |
| Mr. Andrew D. Skibo Ph.D. | Global Head of Biologics Operations | NA |
| Mr. Theodore Scott Yoho | Head of Business Development | NA |
| Dr. Ali I. Fattom Ph.D. | Head of Science & Discovery | NA |
| Dr. Jay Newmark M.B.A., M.D. | Chief Medical Officer | NA |
Insider Trading
Open insider trading| Date | Insider Name | Title | Transaction Type | Shares | Price | Value | SEC |
|---|---|---|---|---|---|---|---|
| Apr 21, 2026 | Financial Lp Hrt | N/A | Sale | 49.71K | $0.69 | $34.30K | SEC |
| Apr 20, 2026 | Financial Lp Hrt | N/A | Sale | 94.46K | $0.75 | $70.85K | SEC |
| Apr 17, 2026 | Financial Lp Hrt | N/A | Purchase | 34.64K | $0.73 | $25.28K | SEC |
| Apr 16, 2026 | Financial Lp Hrt | N/A | Sale | 53.87K | $0.73 | $39.32K | SEC |
| Apr 15, 2026 | Financial Lp Hrt | N/A | Purchase | 92.55K | $0.76 | $70.34K | SEC |
| Apr 14, 2026 | Financial Lp Hrt | N/A | Purchase | 74.35K | $0.77 | $57.25K | SEC |